On August 20, 2026, JPMorgan Chase & Co. bought 4.04 million shares of PHARMARON (03759) at an average price of HKD 34.04 per share, involving about HKD 137.40 million.
Prior to the acquisition, JPMorgan Chase & Co.'s long position in PHARMARON was 26.95 million shares, representing 7.48%; following the acquisition, the holding changed to 30.99 million shares, with the long position ratio rising to 8.6%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.